Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia
Objective: To assess the frequency of HPV-DNA detection, human papillomavirus (HPV) seropositivity, presence of cervical lesions, and its relationship with certain socio-demographic factors in women from Girardot, Colombia from 2006 to 2007. Methods: Nine hundred fifty-three women attending their re...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2009
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/26786
- Acceso en línea:
- https://doi.org/10.1097/OLQ.0b013e318195762c
https://repository.urosario.edu.co/handle/10336/26786
- Palabra clave:
- Papilloma virus infections complications
Seroepidemiologic studies
Uterine cervical neoplasms / epidemiology
Female
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_04d1f0b7f65b6f489fafda8b42655814 |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/26786 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
a63bfae2-3e79-4b18-b806-3c69bb3fabc3-1aa2fd24c-0eb4-4d73-8a15-c2b3025f602d-1c67d367e-96c2-4566-8a39-374ead1a65f6-167db2a8c-efa7-44a9-a45b-daf72b8f0b09-1dd3af730-1a89-42fc-a5de-64665dc12a41-15e48b055-035f-44d8-9867-a21686777f9d-1796530656002020-08-19T14:40:14Z2020-08-19T14:40:14Z2009-05Objective: To assess the frequency of HPV-DNA detection, human papillomavirus (HPV) seropositivity, presence of cervical lesions, and its relationship with certain socio-demographic factors in women from Girardot, Colombia from 2006 to 2007. Methods: Nine hundred fifty-three women attending their regular Pap smear control voluntarily provided cervical cells and blood samples for HPV-DNA analysis and ELISA detection of anti-L1 peptides and virus-like particles (VLPs) antibodies after answering a questionnaire regarding sexual behaviors, number of births, smoking habits, and socio-demographic background. Results: Twenty-six of the 953 women being examined (2.73%) presented cervical cell abnormalities. A frequency of 36.62% (95% CI: 33.52%–39.7%) HPV seropositivity was detected with peptide 18301, 35.36% (95% CI: 32.3%–38.4%) with 18283, and 32.95% (95% CI: 29.9%–36%) with 18294, whereas VLPs detected a 43% seropositivity (95% CI: 39.8%– 46.2%). Antibody frequency found with all peptides was significantly higher in women having cervical abnormalities (atypical squamous cells of undetermined significance and high-grade squamous intraephitelial lesions) compared with those having normal cytologies. Peptide 18283 reported a significantly higher seropositivity (35.71%) in women 44 years old, whereas peptides 18301 and 18294 evidenced a significantly lower seropositivity in those who had never given birth. HR-HPV-DNA was detected in 157 (20.50%) of 766 cervical samples amplifying positively for the -globin housekeeping gene. Conclusion: Peptides 18283, 18294, and 18301 were more specific and more sensitive than VLPs for detecting women with HR-HPV-DNA positive cervical lesions. Therefore, they could be useful in the design of a serological test for detecting HR-HPV-infected women having cervical lesions at a risk of progressing to cervical cancer.application/pdfhttps://doi.org/10.1097/OLQ.0b013e318195762cISSN: 0148-5717EISSN: 1537-4521https://repository.urosario.edu.co/handle/10336/26786engAmerican Sexually Transmitted Diseases Association296No. 5290Sexually Transmitted Diseases, Journal of the American Venereal Disease AssociationVol. 35Sexually Transmitted Diseases, Journal of the American Venereal Disease Association, ISSN: 0148-5717;EISSN: 1537-4521, Vol.35, No.5 (May 2009); pp. 290-296https://journals.lww.com/stdjournal/Fulltext/2009/05000/Prevalence_of_HPV_DNA_and_Anti_HPV_Antibodies_in.5.aspxAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2Sexually Transmitted Diseases, Journal of the American Venereal Disease Associationinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURPapilloma virus infections complicationsSeroepidemiologic studiesUterine cervical neoplasms / epidemiologyFemalePrevalence of HPV-DNA and anti-HPV antibodies in women from girardot, ColombiaPrevalencia de VPH-ADN y anticuerpos anti-VPH en mujeres de girardot, ColombiaarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Leon, SandraSánchez, RicardoCamargo, MilenaMejia, AdrianoUrquiza, MauricioPatarroyo, Manuel EPatarroyo, Manuel A.10336/26786oai:repository.urosario.edu.co:10336/267862021-06-03 00:49:59.657https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia |
dc.title.TranslatedTitle.spa.fl_str_mv |
Prevalencia de VPH-ADN y anticuerpos anti-VPH en mujeres de girardot, Colombia |
title |
Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia |
spellingShingle |
Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia Papilloma virus infections complications Seroepidemiologic studies Uterine cervical neoplasms / epidemiology Female |
title_short |
Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia |
title_full |
Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia |
title_fullStr |
Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia |
title_full_unstemmed |
Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia |
title_sort |
Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia |
dc.subject.keyword.spa.fl_str_mv |
Papilloma virus infections complications Seroepidemiologic studies Uterine cervical neoplasms / epidemiology Female |
topic |
Papilloma virus infections complications Seroepidemiologic studies Uterine cervical neoplasms / epidemiology Female |
description |
Objective: To assess the frequency of HPV-DNA detection, human papillomavirus (HPV) seropositivity, presence of cervical lesions, and its relationship with certain socio-demographic factors in women from Girardot, Colombia from 2006 to 2007. Methods: Nine hundred fifty-three women attending their regular Pap smear control voluntarily provided cervical cells and blood samples for HPV-DNA analysis and ELISA detection of anti-L1 peptides and virus-like particles (VLPs) antibodies after answering a questionnaire regarding sexual behaviors, number of births, smoking habits, and socio-demographic background. Results: Twenty-six of the 953 women being examined (2.73%) presented cervical cell abnormalities. A frequency of 36.62% (95% CI: 33.52%–39.7%) HPV seropositivity was detected with peptide 18301, 35.36% (95% CI: 32.3%–38.4%) with 18283, and 32.95% (95% CI: 29.9%–36%) with 18294, whereas VLPs detected a 43% seropositivity (95% CI: 39.8%– 46.2%). Antibody frequency found with all peptides was significantly higher in women having cervical abnormalities (atypical squamous cells of undetermined significance and high-grade squamous intraephitelial lesions) compared with those having normal cytologies. Peptide 18283 reported a significantly higher seropositivity (35.71%) in women 44 years old, whereas peptides 18301 and 18294 evidenced a significantly lower seropositivity in those who had never given birth. HR-HPV-DNA was detected in 157 (20.50%) of 766 cervical samples amplifying positively for the -globin housekeeping gene. Conclusion: Peptides 18283, 18294, and 18301 were more specific and more sensitive than VLPs for detecting women with HR-HPV-DNA positive cervical lesions. Therefore, they could be useful in the design of a serological test for detecting HR-HPV-infected women having cervical lesions at a risk of progressing to cervical cancer. |
publishDate |
2009 |
dc.date.created.spa.fl_str_mv |
2009-05 |
dc.date.accessioned.none.fl_str_mv |
2020-08-19T14:40:14Z |
dc.date.available.none.fl_str_mv |
2020-08-19T14:40:14Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1097/OLQ.0b013e318195762c |
dc.identifier.issn.none.fl_str_mv |
ISSN: 0148-5717 EISSN: 1537-4521 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/26786 |
url |
https://doi.org/10.1097/OLQ.0b013e318195762c https://repository.urosario.edu.co/handle/10336/26786 |
identifier_str_mv |
ISSN: 0148-5717 EISSN: 1537-4521 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
296 |
dc.relation.citationIssue.none.fl_str_mv |
No. 5 |
dc.relation.citationStartPage.none.fl_str_mv |
290 |
dc.relation.citationTitle.none.fl_str_mv |
Sexually Transmitted Diseases, Journal of the American Venereal Disease Association |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 35 |
dc.relation.ispartof.spa.fl_str_mv |
Sexually Transmitted Diseases, Journal of the American Venereal Disease Association, ISSN: 0148-5717;EISSN: 1537-4521, Vol.35, No.5 (May 2009); pp. 290-296 |
dc.relation.uri.spa.fl_str_mv |
https://journals.lww.com/stdjournal/Fulltext/2009/05000/Prevalence_of_HPV_DNA_and_Anti_HPV_Antibodies_in.5.aspx |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
American Sexually Transmitted Diseases Association |
dc.source.spa.fl_str_mv |
Sexually Transmitted Diseases, Journal of the American Venereal Disease Association |
institution |
Universidad del Rosario |
dc.source.instname.none.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.none.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1818106675123453952 |